Business Wire

Global Study: 73% of Shoppers Using AI in Shopping Journey - But Merchants Face New Agentic Commerce Risks

20.10.2025 15:00:00 EEST | Business Wire | Press release

Share

Riskified (NYSE: RSKD), a global leader in ecommerce fraud prevention and risk intelligence, today released findings from a survey highlighting the increased adoption of agentic shopping, and the rising threat it poses to merchants.

Based on a global survey of more than 5,000 consumers, the research reveals a defining moment for ecommerce: nearly three in four shoppers (73%) are already using AI in their shopping journey. Shoppers are embracing AI assistants like ChatGPT for product ideas (45%), to summarize reviews (37%), and to compare prices (32%). While only 13% say they’ve completed a purchase after being referred by an AI assistant, 70% are at least somewhat comfortable with an AI agent making purchases on their behalf. More than half (58%) are likely to use these tools for gift shopping this year, marking the beginning of the first truly AI-powered holiday season, where convenience for consumers may come with heightened exposure for merchants who may bear the liability for this uncharted domain.

“AI shopping agents may make buying easier for consumers, but they also blur the lines of accountability for fraud and policy abuse,” said Jeff Otto, Chief Marketing Officer at Riskified. “When an AI shopping agent makes a purchase, is the merchant still liable when a dispute occurs - even though the shopper never visited the merchant’s site during checkout? That uncertainty creates new risks for everyone involved. A disputed charge could stem from a hijacked AI account or even a legitimate customer claiming their AI assistant made a mistake. In each case, the liability remains murky, and data transparency is in short supply.”

Fraudsters are poised to leverage advancements in agentic commerce to their end. Already enabled by AI themselves, fraud rings will look to exploit gaps in identity verification, account security, customer service claims, and payment flows. What feels like a smoother shopping experience for consumers can quickly become a surge in disputes and chargebacks, leaving the merchant with costs they will need to absorb. Businesses stand to face significant disadvantages, many of which are reflected in consumers' top concerns.

Payment security is the main worry for nearly one in three shoppers (32%), followed by privacy (26%), potential mistakes (18%), and loss of control (17%). Despite these fears, trust in AI is closing in on traditional channels: 36% of consumers now trust AI to influence their purchases, nearly matching the 38% who rely on in-store associates. Only 25% prefer to shop online without the aid of AI.

Given this evolution in consumer behavior, alongside the rollout of the Agentic Commerce Protocol (ACP), an open standard that enables shoppers to complete purchases through AI interfaces, merchant fraud teams should focus on the following strategic imperatives:

  • Educate executive leadership: Fraud teams are uniquely positioned to understand the risk-reward trade-off of agentic commerce. They must proactively educate their organizations about the new vectors for fraud and abuse to ensure leadership understands the full picture before integrating these new technologies.
  • Advocate for data transparency: For agentic commerce to be a sustainable partnership, technology platforms like OpenAI must share crucial customer behavioral insights - such as the end user's IP address, device information, and behavioral signals - with merchants. Without this visibility, merchants cannot make informed decisions, and fraud and abuse could overwhelm the system.
  • Leverage shared intelligence: In an agentic world where merchants have less direct data, partnering with networked fraud intelligence platforms becomes even more critical. Partnering with Riskified can restore some of the context lost in agentic transactions by connecting data points across a global community of merchants.

Otto stated, “Fraud teams are the natural leaders for agentic commerce safety because they're hardwired to see both the opportunity and the risk. Their expertise isn't about saying 'no' to innovation; it's about building the guardrails that allow the company to say 'yes' confidently. They are essential to ensuring that exciting new channels like this become sustainable revenue drivers, not vectors for fraud and abuse.”

Riskified empowers merchants to thrive in the dynamic world of agentic commerce with innovative tools designed to ensure both growth and security, while providing guarantees to offset financial liability for agentic fraud chargebacks.Read more about our point of view and how Riskified helps merchants embrace this future of ecommerce with confidence.

About the Survey

Riskified conducted an online survey from September through October 2025, sampling 5,400 consumers ages 18 to 64 across multiple markets, with representation from the U.S., U.K., Brazil, Mexico, Singapore, Australia, China, the Netherlands and the UAE. Respondents are consumers who made an online purchase within the last three months.

About Riskified

Riskified (NYSE: RSKD) empowers businesses to unleash ecommerce growth by outsmarting risk. Many of the world’s biggest brands and publicly traded companies selling online rely on Riskified for guaranteed protection against chargebacks, to fight fraud and policy abuse at scale, and to improve customer retention. Developed and managed by the largest team of ecommerce risk analysts, data scientists, and researchers, the Riskified ecommerce risk management platform analyzes the individual behind each interaction to provide real-time decisions and robust identity-based insights. Learn more at www.riskified.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251020127097/en/

Contacts

Corporate Communications:
Cristina Dinozo
Senior Director of Communications
press@riskified.com

Investor Relations:
Chett Mandel
Head of Investor Relations
ir@riskified.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye